Medical Devices for Mood and Sleep

Overview

Raised to Date: Raised: $36,090

Total Commitments ($USD)

Platform

StartEngine

Start Date

02/24/2023

Close Date

02/24/2024

Min. Goal

$491

Max. Goal

$10,350,000

Min. Investment

$491

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$10.67

Pre-Money Valuation

$100,280,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

03/23/2023

Days Remaining

338

% of Min. Goal

7,353%

% of Max. Goal

0%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,337

# of Investors

18

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2019

Industry

Fitness & Wellness

Tech Sector

Medtech

Distribution Model

B2C

Margin

High

Capital Intensity

High

Location

Brooklyn, New York

Business Type

Growth

Fisher Wallace Laboratories, with a valuation of $83.08 million, is raising funds on StartEngine through Reg A+ crowdfunding. The company manufactures and sells wearable medical devices for mood and sleep disorders, including insomnia, anxiety, and depression. The product of Fisher Wallace Laboratories, the Fisher Wallace Stimulator, stimulates the brain to produce serotonin and modulates brainwave activity. The company has generated $40 million in lifetime revenue and has 14,000 prescribers and 100,000 customers. Kelly Roman and Charles Fisher founded Fisher Wallace in August 2019. The current crowdfunding campaign has a maximum target of $10.35 million. The campaign proceeds will be used for research and development, working capital, company employment, and marketing.

Balance Sheet

Cash and Cash Equivalents

$1,929,380

Total Assets

$1,999,403

Accounts Payable & Accrued Liabilities

$966,198

Long Term Debt

$576,525

Total Liabilities

$1,542,723

Total Stockholders' Equity

$456,680

Total Liabilities and Equity

$1,999,403

Statement of Comprehensive Income Information

Total Revenues

$4,230,290

Costs & Expenses Applicable to Rev

$623,703

Net Income

$3,606,587

Earnings Per Share - Basic

$-0.47

Earnings Per Share - Diluted

$-0.47

Auditor: IndigoSpire CPAs & Advisors
Financials as of: 02/24/2023
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Fisher Wallace Laboratories 02/24/2024 StartEngine $100,280,000 $36,090 Equity - Common Active RegA+
Fisher Wallace 02/20/2023 StartEngine $81,567,588 $1,281,201 Equity - Common Funded RegCF
Fisher Wallace Laboratories 09/01/2022 StartEngine $81,236,323 $357,719 Equity - Common Funded RegCF
Fisher Wallace Laboratories 05/27/2022 StartEngine $80,048,889 $1,279,724 Equity - Common Funded RegCF
Fisher Wallace Laboratories 10/26/2021 StartEngine $40,000,000 $5,010,683 Equity - Common Funded RegA+
Fisher Wallace Laboratories 03/09/2020 StartEngine $15,000,000 $1,056,480 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Are you the founder of Fisher Wallace Laboratories? Create your account today to claim this raise page.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Fisher Wallace Laboratories on StartEngine 2023
Platform: StartEngine
Security Type: Equity - Common
Valuation: $100,280,000

Follow company

Follow Fisher Wallace Laboratories on StartEngine 2023
View on StartEngine